Effects of in‐hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease

Shunji Koya(Kurume University Hospital), Takuji Torimura(Omuta hospital), Minami Imanaga(Kurume University Hospital), Shigeo Shimose(Kurume University), Ryoko Taira(Kurume University Hospital), Hiroo Matsuse(Kurume University), Emiko Goto(Kurume University Hospital), Hiromichi Saito(Kurume University Hospital), Naoto Shiba(Kurume University), Yoshiko Matsushita(Kurume University Hospital), Hideki Iwamoto, Ayu Nagamatsu(Kurume University Hospital), Ryoko Kuromatsu(Kurume University), Ryuki Hashida(Kurume University), Takashi Niizeki(Kurume University), Takumi Kawaguchi(Kurume University), Tomotake Shirono(Kurume University), Keisuke Hirota(Kurume University Hospital), Hiroko Miura(Kurume University Hospital)
Hepatology Research
April 10, 2016
10.1111/hepr.12718
Cited by 71

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504